DiaMedica Therapeutics Inc.
Balance Sheet
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $15.6M | $3.0M | $4.5M | $4.7M | $4.7M | $7.4M | $3.9M | $16.8M |
| Accounts Receivable | $258.0K | $236.0K | $369.0K | $82.0K | $130.0K | $340.0K | $823.0K | $780.0K |
| Inventory | — | — | — | — | — | — | — | — |
| Total Current Assets | $60.6M | $44.6M | $53.7M | $33.8M | $45.4M | $27.9M | $8.8M | $18.0M |
| Property, Plant & Equipment | $145.0K | $148.0K | $131.0K | $136.0K | $70.0K | $74.0K | $64.0K | $96.0K |
| Goodwill | — | — | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | — | — | — | — | — | — |
| Total Assets | $61.4M | $46.3M | $54.2M | $34.4M | $45.6M | $28.1M | $9.1M | $18.3M |
| Liabilities | ||||||||
| Accounts Payable | $1.5M | $940.0K | $926.0K | $734.0K | $509.0K | $1.1M | $182.0K | $483.0K |
| Total Current Liabilities | $5.1M | $5.4M | $2.8M | $2.2M | $1.5M | $2.0M | $1.3M | $1.3M |
| Long-Term Debt | — | — | — | — | — | — | — | — |
| Total Liabilities | $5.3M | $5.6M | $3.1M | $2.6M | $1.5M | $2.1M | $1.4M | $1.3M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-172.8M | $-140.0M | $-115.6M | $-96.2M | $-82.5M | $-68.9M | $-56.6M | $-46.0M |
| Total Stockholders' Equity | $56.1M | $40.7M | $51.1M | $31.8M | $44.0M | $26.0M | $7.6M | $17.0M |
If something is too hard, we move on to something else. What could be simpler than that?